MYLAN WIXELA INHUB Manual page 2

When using your Wixela
aware of these important components
For more information and to watch the How to Use video, visit
Important Safety Information
• WIXELA INHUB contains salmeterol, the same medicine found in SEREVENT
LABA medicines such as salmeterol when used alone increase the risk of hospitalizations and death from asthma
problems. WIXELA INHUB contains an ICS and a LABA. When an ICS and LABA are used together, there is not a
significant increased risk in hospitalizations and death from asthma problems.
Do not use WIXELA INHUB to treat sudden breathing problems from asthma or COPD. Always have a rescue inhaler
•
with you to treat sudden symptoms.
• Do not use WIXELA INHUB if you have a severe allergy to milk proteins. Do not use WIXELA INHUB if you are allergic
to any of the ingredients in the products. Ask your healthcare provider if you are not sure.
• Do not use WIXELA INHUB more often than prescribed.
• Do not take WIXELA INHUB with other medicines that contain a LABA for any reason.
• Tell your healthcare provider about all the medicines you take and about all of your health conditions.
Common side effects of WIXELA INHUB for asthma include upper respiratory tract infection, throat irritation,
•
hoarseness and voice changes, thrush in your mouth or throat, bronchitis, cough, headache, and nausea and vomiting. In
children with asthma, infections in the ear, nose, and throat are common.
• Common side effects of WIXELA INHUB for COPD include thrush in your mouth or throat, throat irritation, hoarseness
and voice changes, viral respiratory infections, headache, and muscle and bone pain.
Click Here for full Prescribing Information and Patient Information for full Instructions For Use.
For additional information please contact us at 800-395-3376.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
1-800-FDA-1088.
WIXELA and INHUB are trademarks of Mylan Pharmaceuticals Inc.
ADVAIR DISKUS and SEREVENT are registered trademarks of the GSK group of companies.
The Mylan logo is a registered trademark of Mylan Inc.
© 2019 Mylan Pharmaceuticals Inc. All rights reserved. WIX-2018-0017
Inhub
™ ™ please be
Dose counter
Mouthpiece
Yellow lever
Air vents
Mouthpiece cover
Grip
DOSE COUNTER
(fluticasone
propionate and
salmeterol inhalation powder, USP)
100/
50
Pouch opened:
Discard 1 month after
removal from the foil pouch.
60 doses left
Your dose counter will be set at 60
when you first receive your INHUB.
(fluticasone
propionate and
salmeterol inhalation powder, USP)
100/
50
Pouch opened:
Discard 1 month after
removal from the foil pouch.
9 doses left
After you have taken 51 doses, a red indicator will be
present. This indicator warns you there are 9 or fewer
doses left and is a reminder to get a refill.
sone
nate and
erol inhalation powder, USP)
/
50
d:
nth after
the foil pouch.
0 doses left
The dose counter will read 0 and the lever will not
reach the end of the purple arrows when
there are no doses remaining.
www.wixela.com
(salmeterol xinafoate inhalation powder).
®
www.fda.gov/medwatch
Rx only
00000000
doses
Rx only
00000000
9
doses
Rx only
00000000
0
doses
or call